A critical next step will involve systematic delineation of circHIPK3’s network-level regulatory architecture in gallbladder carcinogenesis, including in vivo validation of its interaction with ALYREF and functional characterization of ALYREF’s role in tumor progression. This evidence concerns the gene ALYREF and neoplasm.